Krege JH - Search Results

1

Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene.

Cosman F, Keaveny TM, Kopperdahl D, Wermers RA, Wan X, Krohn KD, Krege JH. Cosman F, et al. Among authors: krege jh. J Bone Miner Res. 2013 Jun;28(6):1328-36. doi: 10.1002/jbmr.1853. J Bone Miner Res. 2013. PMID: 23281041 Free article. Clinical Trial.

2

Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.

Cosman F, Wermers RA, Recknor C, Mauck KF, Xie L, Glass EV, Krege JH. Cosman F, et al. Among authors: krege jh. J Clin Endocrinol Metab. 2009 Oct;94(10):3772-80. doi: 10.1210/jc.2008-2719. Epub 2009 Jul 7. J Clin Endocrinol Metab. 2009. PMID: 19584192 Clinical Trial.

3

Changes in vitamin D metabolites during teriparatide treatment.

Cosman F, Dawson-Hughes B, Wan X, Krege JH. Cosman F, et al. Among authors: krege jh. Bone. 2012 Jun;50(6):1368-71. doi: 10.1016/j.bone.2012.02.635. Epub 2012 Mar 9. Bone. 2012. PMID: 22426307 Clinical Trial.

4

Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis.

Eriksen EF, Keaveny TM, Gallagher ER, Krege JH. Eriksen EF, et al. Among authors: krege jh. Bone. 2014 Oct;67:246-56. doi: 10.1016/j.bone.2014.07.014. Epub 2014 Jul 15. Bone. 2014. PMID: 25053463 Free article. Review.

5

Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis.

Krege JH, Wan X. Krege JH, et al. Bone. 2012 Jan;50(1):161-4. doi: 10.1016/j.bone.2011.10.018. Epub 2011 Oct 22. Bone. 2012. PMID: 22036910 Clinical Trial.

6

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

Wermers RA, Recknor CP, Cosman F, Xie L, Glass EV, Krege JH. Wermers RA, et al. Among authors: krege jh. Osteoporos Int. 2008 Jul;19(7):1055-65. doi: 10.1007/s00198-007-0557-z. Epub 2008 Feb 19. Osteoporos Int. 2008. PMID: 18283386 Clinical Trial.

7

Association between teriparatide adherence and healthcare utilization and costs among hip fracture patients in the United States.

Zhao Y, Johnston SS, Smith DM, McMorrow D, Krege J, Krohn K. Zhao Y, et al. Bone. 2014 Mar;60:221-6. doi: 10.1016/j.bone.2013.12.016. Epub 2013 Dec 18. Bone. 2014. PMID: 24361596

8

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

Saag KG, Zanchetta JR, Devogelaer JP, Adler RA, Eastell R, See K, Krege JH, Krohn K, Warner MR. Saag KG, et al. Among authors: krege jh. Arthritis Rheum. 2009 Nov;60(11):3346-55. doi: 10.1002/art.24879. Arthritis Rheum. 2009. PMID: 19877063 Free article. Clinical Trial.

9

Benefits and risks of raloxifene by vertebral fracture status.

Sontag A, Wan X, Krege JH. Sontag A, et al. Among authors: krege jh. Curr Med Res Opin. 2010 Jan;26(1):71-6. doi: 10.1185/03007990903427082. Curr Med Res Opin. 2010. PMID: 19908937 Clinical Trial.

10

Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.

Beall DP, Feldman RG, Gordon ML, Gruber BL, Lane JM, Valenzuela G, Yim D, Alam J, Krege JH, Krohn K. Beall DP, et al. Among authors: krege jh. Osteoporos Int. 2016 Mar;27(3):1191-1198. doi: 10.1007/s00198-015-3353-1. Epub 2015 Nov 10. Osteoporos Int. 2016. PMID: 26556737 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters